Correlating in vitro scratch test with in vivo contact free occlusal area wear of contemporary dental composites.

Objectives: The aims of this study are to determine the extent to which the ranking order for clinical Contact-Free-Occlusal-Area (CFOA) wear performance of composites correlates with the ranking based on in vitro scratch hardness, and to analyze the extent to which the microstructure influences the overall trend.

Materials And Methods: The patient data and CFOA wear measurements of 16 Tetric-C, 17 Tetric-EC, 16 Gradia-DP, 18 Filtek Supreme, 19 Z100 restorations in 31 subjects (8 males, 23 females) of two randomized clinical trials were fitted in a mixed-effect model. The in vivo performance of the restoratives was summarized by ranking the estimated material-related coefficients in the model.

Nanofilled and microhybrid composite restorations: Five-year clinical wear performances.

Objectives: To compare the clinical wear performance of nanofilled restorations (Filtek Supreme) against microhybrid restorations (Z100) in a 5-year randomized clinical trial to evaluate the wear rate and the influence of subject-, operator- and restoration-related variables on wear rate.

Materials And Methods: 18 Filtek Supreme and 17 Z100 restorations were placed in human molars (split-mouth-model) and bonded with Single Bond/Scotch Bond Adhesive. Restorations were recalled at baseline, 6-, 12-months and at annual intervals until 5-years of clinical service.

Enamel loss and adhesive remnants following bracket removal and various clean-up procedures in vitro.

This study evaluated the enamel loss and composite remnants after debonding and clean-up. The tested null hypothesis is that there are no differences between different polishing systems regarding removing composite remnants without damaging the tooth surface. Brackets were bonded to 75 extracted human molars and removed after a storage period of 100 hours.

Nanohybrid and microfilled hybrid versus conventional hybrid composite restorations: 5-year clinical wear performance.

Unlabelled: The 5-year findings of a randomized clinical trial testing the null hypothesis that there are no differences between the clinical-wear performances of nano-, microfilled-, and conventional hybrids placed in class I and class II cavities are reported. Effects of subject-, operator-, and restoration-related variables on wear were assessed. Sixteen Tetric-C, 17 Tetric-EC, and 16 Gradia-DP restorations were placed in human molars and recalled at baseline, 6 months and at yearly intervals.

Three-year randomised clinical trial to evaluate the clinical performance, quantitative and qualitative wear patterns of hybrid composite restorations.

The aim of the study was to compare the clinical performance, quantitative and qualitative wear patterns of conventional hybrid (Tetric Ceram), micro-filled hybrid (Gradia Direct Posterior) and nano-hybrid (Tetric EvoCeram, TEC) posterior composite restorations in a 3-year randomised clinical trial. Sixteen Tetric Ceram, 17 TEC and 16 Gradia Direct Posterior restorations were placed in human molars and evaluated at baseline, 6, 12, 24 and 36 months of clinical service according to US Public Health Service criteria. The gypsum replicas at each recall were used for 3D laser scanning to quantify wear, and the epoxy resin replicas were observed under scanning electron microscope to study the qualitative wear patterns.

Three-year randomized clinical trial to evaluate the clinical performance and wear of a nanocomposite versus a hybrid composite.

Objectives: Compare the 3-year clinical performance (wear as an additional parameter) of a nanocomposite and a microhybrid composite, versus ADA guidelines (2001) using direct (clinical/USPHS) and indirect (quantitative/3D laser scan and qualitative/SEM) methods, in parallel.

Materials And Methods: 18 Filtek Supreme and 17 Z100 restorations were placed in molars (split mouth model) and bonded with Single bond Adhesive. Restorations were evaluated at baseline and 6-, 12-, 24-, 36-months of clinical service according to modified USPHS criteria.